Displaying drugs 1801 - 1825 of 3402 in total
WU-NK-101
WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product
Investigational
Matched Name: … WU-NK-101 …
Matched Description: … WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product …
Matched Description: … WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product …
SIS-101-ADO
SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis Type 2 (ADO2).
Investigational
Matched Name: … SIS-101-ADO …
Matched Description: … SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis …
Matched Description: … SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis …
9-(2-carboxyethyl)-10-methylanthracene endoperoxide
Experimental
Matched Synonyms: … [2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE …
Matched Name: … 9-(2-carboxyethyl)-10-methylanthracene endoperoxide …
Matched Iupac: … 3-[(1s,8s)-8-methyl-15,16-dioxatetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9(14),10,12-hexaen-1- …
Matched Name: … 9-(2-carboxyethyl)-10-methylanthracene endoperoxide …
Matched Iupac: … 3-[(1s,8s)-8-methyl-15,16-dioxatetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2,4,6,9(14),10,12-hexaen-1- …
P-BCMA-101
P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.
Investigational
Matched Name: … P-BCMA-101 …
Matched Description: … P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology. …
Matched Description: … P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology. …
ADL 10-0101
ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment of inflammatory pain, itch and visceral pain. Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at...
Investigational
Matched Name: … ADL 10-0101 …
Matched Description: … ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. ... Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment ... Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at therapeutic …
Matched Description: … ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. ... Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment ... Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at therapeutic …
10-decarboxymethylaclacinomycin A
Experimental
Matched Name: … 10-decarboxymethylaclacinomycin A …
Matched Iupac: … (8S,10S)-10-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-{[(2R,4S,5R,6S)-4-hydroxy-6-methyl-5-{[(2R,6R)-6-methyl …
Matched Iupac: … (8S,10S)-10-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-{[(2R,4S,5R,6S)-4-hydroxy-6-methyl-5-{[(2R,6R)-6-methyl …
3-(10-methyl-9-anthryl)propanoic acid
Experimental
Matched Synonyms: … 3-(10-methyl-9-anthryl)propionic acid ... 3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
(R)-tacrine(10)-hupyridone
Experimental
Matched Name: … (R)-tacrine(10)-hupyridone …
Matched Iupac: … (5R)-5-({10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino)-1,2,5,6,7,8-hexahydroquinolin-2-one …
Matched Iupac: … (5R)-5-({10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino)-1,2,5,6,7,8-hexahydroquinolin-2-one …
(S)-tacrine(10)-hupyridone
Experimental
Matched Name: … (S)-tacrine(10)-hupyridone …
Matched Iupac: … (5S)-5-({10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino)-1,2,5,6,7,8-hexahydroquinolin-2-one …
Matched Iupac: … (5S)-5-({10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}amino)-1,2,5,6,7,8-hexahydroquinolin-2-one …
10-formyl-5,8,10-trideazafolic acid
Experimental
Matched Name: … 10-formyl-5,8,10-trideazafolic acid …
SALOPHEN-10-PROPIONATE IRON CHELATE
Experimental
Matched Name: … SALOPHEN-10-PROPIONATE IRON CHELATE …
Salophen-10-carboxylate iron chelate
Experimental
Matched Name: … Salophen-10-carboxylate iron chelate …
(10R)-10-formyl-5,8,10-trideazafolic acid
Experimental
Matched Name: … (10R)-10-formyl-5,8,10-trideazafolic acid …
Nevanimibe
Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
Investigational
Matched Synonyms: … Atr-101 free base …
Matched Description: … Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment …
Matched Description: … Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment …
(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene
Experimental
Matched Name: … (9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(9R,10R)-10-hydroxy-9,10-dihydrophenanthren-9- …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(9R,10R)-10-hydroxy-9,10-dihydrophenanthren-9- …
(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene
Experimental
Matched Name: … (9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(9S,10S)-10-hydroxy-9,10-dihydrophenanthren-9- …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(9S,10S)-10-hydroxy-9,10-dihydrophenanthren-9- …
(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid
Experimental
Matched Name: … (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid …
Matched Iupac: … (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid …
Matched Iupac: … (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid …
3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione
Experimental
Matched Name: … 3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione …
Ganglioside GM1
Investigational
Matched Synonyms: … Ganglioside gm1 (d18:1/18:0) ... Monosialotetrahexosylganglioside (d18:1/18:0) …
(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE
Experimental
Matched Name: … (9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE …
(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate
Experimental
Matched Name: … (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate …
Displaying drugs 1801 - 1825 of 3402 in total